Studying the effects of Ruta chalepensis on blood glucose, cholesterol and triglycerides levels in rats.
Abstract
Ruta chalepensis is a native plant to Eurasia and North Africa, it has been used in traditional herbal medicine for various purposes. This includes For example, as abortifacient, digestive, anti-inflammatory, analgesic and anti- parasites. In folk Libyan medicine it is believed to be helpful for diabetes and dyslipidemia. Water and alcoholic extracts of Ruta chalepensis were tested in rats for potential lowering effects on blood glucose, cholesterol and/or triglycerides. In this study, the water and alcohol extracts was administrated to normal rat and blood glucose, cholesterol and triglycerides were estimated with urine output, food and water intake as biological markers for blood glucose. In unexpected manner, neither water nor alcoholic extracts decrease blood glucose, cholesterol and/or triglycerides in rats. However, high concentrations of alcoholic extract (15 and 20%w/v) resulted in a significant elevation of blood glucose levels. Administration of alcoholic extract 7.5%w/v daily for 7 days produced increase in urine output on every day. The results point to a potential risk of using the plant as an anti-diabetic remedy, also indicate to the presence of material(s) that might have diuretic effect.
References
Al-sagair, Othman. 2004. “Persistent Hyperinsulinemia as a Result of Infusion with Ruta Chalepensis.†4(4):625–29.
Albrki, W. M., A-n Y. Elzouki, and O. A. Tashani. 2007. “Lipid Profiles in Libyan Type II Diabetics.†1(1):18–23.
Aouadhi, Ch, H. Ghazghazi, S. Hamrouni, B. Hasnaoui, and A. Maaroufi. 2013. “In Vitro Antifungal Activity of the Essential Oil and the Methanolic Extract of Ruta Chalepensis.†Archives de l’Institut Pasteur de Tunis 90(1–4):39–46.
Azwanida, NN. 2015. “A Review on the Extraction Methods Use in Medicinal Plants, Principle, Strength and Limitation.†Medicinal & Aromatic Plants 4(3):1–6.
D ’avigdor, Elizabeth, Hans Wohlmuth, Zemede Asfaw, and Tesfaye Awas. 2014. “The Current Status of Knowledge of Herbal Medicine and Medicinal Plants in Fiche, Ethiopia.†Journal of Ethnopharmacology and Ethnomedicine 10:1–33.
Ganeshpurkar, Aditya and Ajay K. Saluja. 2017. “The Pharmacological Potential of Rutin.†Saudi Pharmaceutical Journal 25(2):149–64.
Günaydin a, Keriman and Sezer Savci b †. 2005. “Phytochemical Studies on Ruta chalepensİs (LAM.) Lamarck.†Natural Product Research 19(3):203–10.
Hamdiken, Malika, Samira Bouhalit, and Zine Kechrid. 2017. “Effect of Ruta Chalepensis on Zinc, Lipid Profile and Antioxidant Levels in the Blood and Tissue of Streptozotocin-Induced Diabetes in Rats Fed Zinc-Deficient Diets.†Canadian Journal of Diabetes.
Herrmann, W., C. Schütz, and W. Reuter. 1983. “[Determination of HDL-Cholesterol].†Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete 38(1):17–22.
Lott, J. A. and K. Turner. 1975. “Evaluation of Trinder’s Glucose Oxidase Method for Measuring Glucose in Serum and Urine.†Clinical Chemistry 21(12):1754–60.
Louhaichi, M., A. K. Salkini, H. E. Estita, S. Belkhir, and H. E. Belkhir. 2011. “Initial Assessment of Medicinal Plants Across the Libyan Mediterranean Coast.†Advances in Environmental Biology 5(2):359–70.
Miguel, Elia San. 2009. “Rue (Ruta L., Rutaceae) in Traditional Spain: Frequency and Distribution of Its Medicinal and Symbolic Applications.†http://dx.doi.org/10.1663/0013-0001(2003)057[0231:RRLRIT]2.0.CO;2. Retrieved January 23, 2018 (http://www.bioone.org/doi/abs/10.1663/0013-0001(2003)057%5B0231:RRLRIT%5D2.0.CO%3B2).
Park, Jun Hwan and Hoi Seon Lee. 2015. “Inhibitory Effects of Quinoline Isolated from Ruta Chalepensis and Its Structurally Related Derivatives against ??-Amylase or ??-Glucosidase.†Journal of Applied Biological Chemistry 58(1):5–8.
Purnell, Jonathan Q. et al. 2013. “The Effect of Excess Weight Gain with Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Study.†Circulation 127(2):180–87.
